Analgesic agent for newborn or fetal subjects
AssigneeProtexeon Limited
InventorsNicholas Peter Franks, Mervyn Maze
Life of this patent
Estimating the term…
Abstract
In a first aspect, the present invention relates to the use of xenon in the preparation of a medicament for providing analgesia in a newborn subject and/or a fetal subject. In a second aspect, the invention relates to a method of providing analgesia in a newborn subject, the method comprising administering to the subject a therapeutically effective amount of xenon. In a third aspect, the invention relates to a method of providing analgesia in a fetal subject, the method comprising administering to the mother of the fetal subject a therapeutically effective amount of xenon for both the mother and fetal subject.
Claims18
A method of providing analgesia in a human newborn subject, the method comprising administering a therapeutically effective amount of an analgesic to a human newborn subject experiencing pain or stress sufficient to necessitate administration of the analgesic, wherein the analgesic is xenon.
A method of providing analgesia in a human fetal subject, the method comprising administering a therapeutically effective amount of an analgesic to a mother of a human fetal subject, the fetal subject experiencing pain or stress sufficient to necessitate administration of the analgesic, wherein the analgesic is xenon.
Dependencies are inferred from the claim text.